Ablynx NV

Delisted

CIK 1617582fmd_1Y1E99A2XGTQC7ZRZG9EG8PGXZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods

Income Statement · Annual · Millions · EUR
Line item	FY2015	FY2016	FY2017
Total revenues	78	85	56
Research and development	83	100	91
Operating income	(17)	(29)	(54)
Interest expense	39	7	55
Income before taxes	(55)	(1)	(109)
Income tax expense	0	0	0
Net income from continuing operations	(55)	(1)	(109)
Net income	(55)	(1)	(109)